DE69816102D1 - Kondensierte thiophenderivate und ihre medizinische anwendung - Google Patents

Kondensierte thiophenderivate und ihre medizinische anwendung

Info

Publication number
DE69816102D1
DE69816102D1 DE69816102T DE69816102T DE69816102D1 DE 69816102 D1 DE69816102 D1 DE 69816102D1 DE 69816102 T DE69816102 T DE 69816102T DE 69816102 T DE69816102 T DE 69816102T DE 69816102 D1 DE69816102 D1 DE 69816102D1
Authority
DE
Germany
Prior art keywords
compound
condensed thiophene
medical application
thiophene derivatives
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69816102T
Other languages
German (de)
English (en)
Inventor
Koji Seio
Hiroshi Tanaka
Toshiyuki Kohara
Kenji Hashimoto
Masatake Fujimura
Hideki Horiuchi
Hiroshi Yasumatsu
Koreichi Kimura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Pharma Corp
Original Assignee
Mitsubishi Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27322564&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69816102(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mitsubishi Pharma Corp filed Critical Mitsubishi Pharma Corp
Application granted granted Critical
Publication of DE69816102D1 publication Critical patent/DE69816102D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE69816102T 1997-09-02 1998-08-31 Kondensierte thiophenderivate und ihre medizinische anwendung Expired - Lifetime DE69816102D1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP23670097 1997-09-02
JP27777197 1997-10-09
JP16572598 1998-06-12
PCT/JP1998/003915 WO1999011647A1 (en) 1997-09-02 1998-08-31 Fused thiophene compounds and medicinal use thereof

Publications (1)

Publication Number Publication Date
DE69816102D1 true DE69816102D1 (de) 2003-08-07

Family

ID=27322564

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69816102T Expired - Lifetime DE69816102D1 (de) 1997-09-02 1998-08-31 Kondensierte thiophenderivate und ihre medizinische anwendung

Country Status (16)

Country Link
US (2) US6271225B1 (cg-RX-API-DMAC7.html)
EP (1) EP1016664B1 (cg-RX-API-DMAC7.html)
JP (2) JP3156933B2 (cg-RX-API-DMAC7.html)
KR (1) KR20010021989A (cg-RX-API-DMAC7.html)
CN (1) CN1268949A (cg-RX-API-DMAC7.html)
AT (1) ATE244245T1 (cg-RX-API-DMAC7.html)
AU (1) AU739385B2 (cg-RX-API-DMAC7.html)
BR (1) BR9814042A (cg-RX-API-DMAC7.html)
CA (1) CA2302409A1 (cg-RX-API-DMAC7.html)
DE (1) DE69816102D1 (cg-RX-API-DMAC7.html)
HU (1) HUP0003718A3 (cg-RX-API-DMAC7.html)
IL (1) IL134812A0 (cg-RX-API-DMAC7.html)
NO (1) NO20001049L (cg-RX-API-DMAC7.html)
NZ (1) NZ503484A (cg-RX-API-DMAC7.html)
RU (1) RU2197491C2 (cg-RX-API-DMAC7.html)
WO (1) WO1999011647A1 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6590083B1 (en) 1999-04-16 2003-07-08 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
US6399582B1 (en) 1999-04-16 2002-06-04 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
US6608053B2 (en) * 2000-04-27 2003-08-19 Yamanouchi Pharmaceutical Co., Ltd. Fused heteroaryl derivatives
US6751036B2 (en) * 2000-08-04 2004-06-15 Seagate Technology Llc Tuning track density for data storage device
US8329924B2 (en) * 2001-06-11 2012-12-11 Vertex Pharmaceuticals (Canada) Incorporated Compounds and methods for the treatment or prevention of Flavivirus infections
EP2363396A1 (en) * 2001-06-11 2011-09-07 Virochem Pharma Inc. Thiophene derivatives as antiviral agents for flavivirus infection
ES2285227T3 (es) 2002-08-05 2007-11-16 Eli Lilly And Company Arilbenzodiazepinas sustituidas con piperazina.
DE60332482D1 (de) 2002-12-10 2010-06-17 Virochem Pharma Inc Verbindungen und methoden zum behandeln oder vorbeugen von flavivirus infektionen
US20040236181A1 (en) * 2003-04-01 2004-11-25 Olympus Corporation In-body information acquiring apparatus and power-supply circuit
CA2536107A1 (en) * 2003-09-09 2005-03-24 Eli Lilly And Company Substituted piperazines of azepines, oxazepines, and thiazepines
RU2248205C1 (ru) * 2003-09-18 2005-03-20 Открытое акционерное общество "Щелковский витаминный завод" Лекарственное средство в виде желатиновой капсулы
EP1713486A4 (en) * 2003-12-02 2009-04-29 Sheldon Leslie James COMBINED THERAPY FOR THE TREATMENT OF DEMENTIA, DEPRESSION AND APATHY
WO2005063771A1 (en) * 2003-12-22 2005-07-14 Teva Pharmaceutical Industries Ltd Methods of preparing olanzapine
US7807828B2 (en) * 2005-08-11 2010-10-05 Hypnion, Inc. Olanzapine analogs and methods of use thereof
SG176488A1 (en) * 2006-11-15 2011-12-29 Virochem Pharma Inc Thiophene analogues for the treatment or prevention of flavivirus infections
PL395468A1 (pl) 2011-06-29 2013-01-07 Adamed Spólka Z Ograniczona Odpowiedzialnoscia Zwiazki amidoalkilopiperazynylowe do leczenia chorób osrodkowego ukladu nerwowego
JP6551671B2 (ja) * 2015-08-11 2019-07-31 国立大学法人 熊本大学 アルツハイマー治療薬
US12365696B2 (en) 2019-05-10 2025-07-22 Dana-Farber Cancer Institute, Inc. Small-molecule focal adhesion kinase (FAK) inhibitors

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL140242B (nl) 1963-03-01 1973-11-15 Wander Ag Dr A Werkwijze voor het bereiden van op de 11-plaats door een basische groep gesubstitueerde dibenz (b.f.)(1.4) oxazepinen.
CH468400A (de) 1965-12-23 1969-02-15 Sandoz Ag Verfahren zur Herstellung neuer Thieno(2,3-b)(1,5)benzothiazepin-4-on-Verbindungen
US3683084A (en) 1969-02-06 1972-08-08 Jean Schmutz Basically substituted heterocycles as anti-emetics
US3726977A (en) 1969-02-06 1973-04-10 Sandoz Ag 2-NITRO-11-(1-PIPERAZINYL)-DIBENZ (b,f) (1,4) OXAZEPINES COMPOSITIONS IN THE TREATMENT OF DEPRESSION
US3962248A (en) * 1972-04-04 1976-06-08 Sandoz, Inc. Process for making 11-piperazino-diazepines, oxazepines, thiazepines and azepines
SU629879A3 (ru) * 1974-11-26 1978-10-25 Лилли Индастриз Лимитед, (Фирма) Способ получени тиено(1,5) бензодиазепинов или их солей
US4115568A (en) 1974-11-26 1978-09-19 Lilly Industries Limited Thieno[3,2-b]-[1,5]benzodiazepines
US4172831A (en) 1974-11-26 1979-10-30 Lilly Industries Limited Thieno-benzodiazepines
GB1533236A (en) * 1975-11-24 1978-11-22 Lilly Industries Ltd Thieno(1,5)benzodiazepine intermediates
US4157444A (en) 1978-03-13 1979-06-05 American Cyanamid Company 10-(Piperazinyl)thieno[3,4-b][1,5]benzoxazepines and 10-(piperazinyl)thieno[3,4-b][1,5]benzothiazepines
GB9009229D0 (en) 1990-04-25 1990-06-20 Lilly Industries Ltd Pharmaceutical compounds
US5538965A (en) 1993-12-23 1996-07-23 Allelix Biopharmaceuticals Inc. Dopamine receptor ligands
US5602121A (en) 1994-12-12 1997-02-11 Allelix Biopharmaceuticals, Inc. Alkyl-substituted compounds having dopamine receptor affinity
US5700445A (en) 1994-12-12 1997-12-23 Allelix Biopharmaceuticals, Inc. N-methyl piperazine compounds having dopamine receptor affinity
US5602124A (en) 1994-12-12 1997-02-11 Allelix Biopharmaceuticals, Inc. 5-HT2 receptor ligands
US5576314A (en) 1994-12-12 1996-11-19 Allelix Biopharmaceuticals Inc. Bicyclic nonane and decane compounds having dopamine receptor affinity
US5602120A (en) 1994-12-12 1997-02-11 Allelix Biopharmaceuticals, Inc. Benzyl-substituted compounds having dopamine receptor affinity
US5561127A (en) 1994-12-19 1996-10-01 Allelix Biopharmaceuticals, Inc. Muscarinic receptor ligands

Also Published As

Publication number Publication date
US6271225B1 (en) 2001-08-07
NZ503484A (en) 2001-10-26
ATE244245T1 (de) 2003-07-15
IL134812A0 (en) 2001-04-30
NO20001049L (no) 2000-04-03
HUP0003718A3 (en) 2002-11-28
NO20001049D0 (no) 2000-03-01
JP3156933B2 (ja) 2001-04-16
KR20010021989A (ko) 2001-03-15
EP1016664A1 (en) 2000-07-05
HUP0003718A2 (hu) 2001-09-28
AU739385B2 (en) 2001-10-11
US20020042411A1 (en) 2002-04-11
EP1016664B1 (en) 2003-07-02
CN1268949A (zh) 2000-10-04
CA2302409A1 (en) 1999-03-11
WO1999011647A1 (en) 1999-03-11
RU2197491C2 (ru) 2003-01-27
JP2001072684A (ja) 2001-03-21
AU8889098A (en) 1999-03-22
US6455521B1 (en) 2002-09-24
EP1016664A4 (en) 2001-01-24
BR9814042A (pt) 2000-10-03
JP4354106B2 (ja) 2009-10-28

Similar Documents

Publication Publication Date Title
ATE244245T1 (de) Kondensierte thiophenderivate und ihre medizinische anwendung
BR0014761A (pt) Derivados de benzodiazepina
ATE404539T1 (de) Kondensierte pyridinderivate
FI941378A0 (fi) Bentsimidatsoliyhdisteitä, niiden käyttö ja valmistus
EE200200716A (et) Ühendid Alzheimeri tõve käitluseks
DE60007768D1 (de) Neue thiazolo(4,5-d)pyrimidinverbindungen
HU9600834D0 (en) Quinazoline derivatives
NO20025517D0 (no) Triazolderivater
PT1337535E (pt) Derivados de benzodiazepina
DK220488D0 (da) Piperazinderivater
ATE377602T1 (de) Morphinanderivate und ihre medizinische anwendung
ATE191485T1 (de) Mercaptoacetylamid-1,3,4,5- tetrahydrobenzo(c)azepin-3-ein disulfidderivate als enkephalinase und ace inhibitoren
DE69505470D1 (de) Pyrrolocarbazol
PT992509E (pt) Novos derivados macrolidos
ATE268751T1 (de) Biphenylamidin-derivate
NO952495D0 (no) Diaryl-5,6-kondenserte heterosykliske syrer som leukotrienantagonister
FI935799A0 (fi) Arylsubstituerade heterocykliska foereningar
DE69823240D1 (de) Immunmodulierende arzneimittelzusammenstellung
PT889044E (pt) Derivados do 5-(heteroaril)alquil-3-oxo-pirido-(1,2-a)benzimidazole-4-carboxamida (pbi) uteis no tratamento de perturbacoes do sistema nervoso central
ATE252546T1 (de) 3-(3-hydroxyphenyl)-3-amino-propionamidderivate
DE69013983D1 (de) 4,5,6,11-Tetrahydrobenzo[6,7]-cycloocta[1,2-b]thiophen-6,11-imine und 6,11-Dihydrobenzo[6,7]-cycloocta[1,2-b]thiophen-6,11-imine.
ATE208761T1 (de) Quinolin-derivate und diese enthaltende pharmazeutische zusammensetzungen
BR9902049A (pt) Derivados 9a,11b-desidro de 9-oxima-3-ceto-6-o-metileritromicina.

Legal Events

Date Code Title Description
8332 No legal effect for de